PRESS RELEASE published on 01/24/2024 at 14:00, 2 years 7 months ago AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
PRESS RELEASE published on 09/28/2023 at 14:00, 2 years 11 months ago AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
PRESS RELEASE published on 08/23/2023 at 14:00, 3 years ago AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
PRESS RELEASE published on 07/06/2023 at 14:00, 3 years 1 month ago AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
PRESS RELEASE published on 04/04/2023 at 14:00, 3 years 5 months ago AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Published on 09/05/2026 at 04:05, 1 day 3 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 1 day 8 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 day 8 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 1 day 9 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 1 day 17 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/06/2026 at 06:00, 1 hour 30 minutes ago CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/06/2026 at 05:15, 2 hours 15 minutes ago Experience AI Companion in Everyday Life at Hisense IFA 2026
Published on 09/05/2026 at 22:20, 9 hours 10 minutes ago PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories
Published on 09/05/2026 at 19:35, 11 hours 55 minutes ago ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026
Published on 09/05/2026 at 14:00, 17 hours 30 minutes ago Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute
Published on 09/04/2026 at 18:57, 1 day 12 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 1 day 13 hours ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 16:00, 1 day 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 1 day 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
